• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Gains Over 1%; Virpax Pharmaceuticals Shares Spike Higher

    7/10/24 12:12:52 PM ET
    $ALAR
    $ICU
    $KZIA
    $LGVN
    Computer Software: Prepackaged Software
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $ALAR alert in real time by email

    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 50 points on Wednesday.

    The Dow traded up 0.10% to 39,329.75 while the NASDAQ rose 0.34% to 18,491.35. The S&P 500 also rose, gaining, 0.24% to 5,590.26.

    Check This Out: Nvidia, Amazon And 2 Other Stocks Insiders Are Selling

    Leading and Lagging Sectors

    Materials shares jumped by 0.7% on Wednesday.

    In trading on Wednesday, consumer discretionary shares fell by 0.2%.

    Top Headline

    The EIA said U.S. crude oil inventories declined by 3.444 million barrels in the week ended July 5, compared to market estimates of a 3.0 million decline.

    Equities Trading UP
                           

    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares shot up 87% to $2.17 after the company announced results for a Swine Model pilot study for Probudur.
    • Shares of Longeveron Inc. (NASDAQ:LGVN) got a boost, surging 51% to $4.3350 after the company announced that the FDA granted Regenerative Medicine Advanced Therapy designation to Lomecel-B for the treatment of mild Alzheimer’s Disease.
    • Kazia Therapeutics Limited (NASDAQ:KZIA) shares were also up, gaining 340% to $0.8431 after the company announced results from GBM-AGILE, a phase II/III study that included an evaluation of paxalisib versus standard of care for patients with glioblastoma.

    Equities Trading DOWN

    • Alarum Technologies Ltd. (NASDAQ:ALAR) shares dropped 24% to $34.01 after the company announced estimated guidance for the first half of 2024.
    • Shares of SeaStar Medical Holding Corporation (NASDAQ:ICU) were down 33% to $8.77 after the company entered into a $10 million registered direct offering of 947,868 shares at $10.55 per share.
    • LegalZoom.com, Inc. (NASDAQ:LZ) was down, falling 27% to $5.76 after the company announced a CEO transition and lowered its full year guidance.

    Also Check This Out: This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

    Commodities

    In commodity news, oil traded up 1.4% to $82.57 while gold traded up 0.6% at $2,382.80.

    Silver traded up 0.3% to $31.15 on Wednesday, while copper rose 1.2% to $4.6305.

    Euro zone

    European shares were higher today. The eurozone's STOXX 600 gained 0.82%, Germany's DAX gained 0.83% and France's CAC 40 rose 0.86%. Spain's IBEX 35 Index rose 1.32%, while London's FTSE 100 rose 0.58%.

    Asia Pacific Markets

    Asian markets closed mostly lower on Wednesday, with Japan's Nikkei gaining 0.61%, Hong Kong's Hang Seng Index declining 0.29%, China's Shanghai Composite Index dipping 0.68% and India's S&P BSE Sensex falling 0.53%.

    Japanese machine tool orders climbed by 9.7% year-over-year to JPY 133,817 million in June compared to a 4.2% rise in the prior month.

    Economics

    • Mortgage applications in the U.S. fell by 0.2% during the first week of July.
    • U.S. wholesale inventories increased by 0.6% month-over-month in May compared to a 0.2% gain in the previous month.
    • The EIA said U.S. crude oil inventories declined by 3.444 million barrels in the week ended July 5, compared to market estimates of a 3.0 million decline.

    Now Read This:

    • How To Earn $500 A Month From Citigroup Stock Ahead Of Q2 Earnings Report
    Get the next $ALAR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALAR
    $ICU
    $KZIA
    $LGVN

    CompanyDatePrice TargetRatingAnalyst
    LegalZoom.com Inc.
    $LZ
    3/4/2026$6.00Equal Weight → Underweight
    Barclays
    LegalZoom.com Inc.
    $LZ
    11/6/2025Mkt Perform → Outperform
    William Blair
    LegalZoom.com Inc.
    $LZ
    8/8/2025$12.00Underperform → Buy
    BofA Securities
    LegalZoom.com Inc.
    $LZ
    5/19/2025$11.00 → $12.00Overweight
    Analyst
    Kazia Therapeutics Limited
    $KZIA
    2/6/2025$3.00Buy
    Maxim Group
    LegalZoom.com Inc.
    $LZ
    1/13/2025$8.00 → $9.00Underweight → Overweight
    Analyst
    Longeveron Inc.
    $LGVN
    12/6/2024$10.00Buy
    ROTH MKM
    LegalZoom.com Inc.
    $LZ
    12/6/2024$9.00Neutral
    UBS
    More analyst ratings

    $ALAR
    $ICU
    $KZIA
    $LGVN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alarum Technologies Reports Fourth Quarter and Full Year 2025 Results

    Revenues for fourth quarter and full year 2025 of $11.8 million and $40.7 million, up 60% and 28% respectively, year-over-year; the strong growth driven by accelerating AI demand Investing strongly in enhancing capabilities, while remaining profitable with FY 2025 net profit of $1.0 million and adjusted EBITDA of $4.4 million TEL AVIV, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq: ALAR, TASE: ALAR) ("Alarum" or the "Company"), a global provider of web data collection solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Financial Highlights of Full Year 2025 2025 revenues of $40.7 million, up 28% ye

    3/19/26 8:00:00 AM ET
    $ALAR
    Computer Software: Prepackaged Software
    Technology

    LegalZoom Launches Free AI-Powered Grant Finder to Help Small Businesses Discover Critical Funding

    New tool simplifies the search for business grants, helping entrepreneurs identify funding opportunities faster LegalZoom.com, Inc. (NASDAQ:LZ), America's #1 online legal services company, today announced the launch of Grant Finder, an AI-powered tool that helps small business owners discover funding opportunities they may have otherwise missed. Access to capital remains one of the biggest challenges entrepreneurs face today. While thousands of grants exist across government and corporate programs, finding relevant opportunities can take hours of manual research, often leading founders to outdated listings, irrelevant programs, and resources locked behind paywalls. LegalZoom's Grant F

    3/19/26 8:00:00 AM ET
    $LZ
    EDP Services
    Technology

    SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

    DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its fourth quarter and year-end 2025 financial results after market close on Wednesday, March 25, 2026, and host a webcast and conference call to discuss its financial results and business progress. Date/Time:Wednesday, March 25, 2026, at 4:30 p.m. ET / 2:30 p.m. MT  Webcast:The live webcast and replay can be found here.  Register for the call:Preregistration is required to attend the live call and can be accessed h

    3/18/26 4:05:00 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    $ALAR
    $ICU
    $KZIA
    $LGVN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    LegalZoom.com downgraded by Barclays with a new price target

    Barclays downgraded LegalZoom.com from Equal Weight to Underweight and set a new price target of $6.00

    3/4/26 8:35:56 AM ET
    $LZ
    EDP Services
    Technology

    LegalZoom.com upgraded by William Blair

    William Blair upgraded LegalZoom.com from Mkt Perform to Outperform

    11/6/25 8:41:44 AM ET
    $LZ
    EDP Services
    Technology

    LegalZoom.com upgraded by BofA Securities with a new price target

    BofA Securities upgraded LegalZoom.com from Underperform to Buy and set a new price target of $12.00

    8/8/25 7:57:18 AM ET
    $LZ
    EDP Services
    Technology

    $ALAR
    $ICU
    $KZIA
    $LGVN
    SEC Filings

    View All

    Longeveron Inc. filed SEC Form 8-K: Other Events

    8-K - Longeveron Inc. (0001721484) (Filer)

    3/24/26 4:01:06 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Kazia Therapeutics Limited

    424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer)

    3/19/26 5:19:24 PM ET
    $KZIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Kazia Therapeutics Limited

    424B3 - KAZIA THERAPEUTICS LTD (0001075880) (Filer)

    3/19/26 5:17:11 PM ET
    $KZIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALAR
    $ICU
    $KZIA
    $LGVN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 3 filed by new insider Weiss Omer

    3/A - Alarum Technologies Ltd. (0001725332) (Issuer)

    3/24/26 4:01:19 PM ET
    $ALAR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Weiss Omer

    3 - Alarum Technologies Ltd. (0001725332) (Issuer)

    3/19/26 4:01:19 PM ET
    $ALAR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Halfon Yehuda

    3 - Alarum Technologies Ltd. (0001725332) (Issuer)

    3/19/26 4:01:21 PM ET
    $ALAR
    Computer Software: Prepackaged Software
    Technology

    $ALAR
    $ICU
    $KZIA
    $LGVN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Baird Jennifer A bought $987 worth of shares (4,200 units at $0.24), increasing direct ownership by 13% to 36,200 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    12/22/25 6:55:38 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Messinger Michael bought $5,098 worth of shares (14,500 units at $0.35), increasing direct ownership by 483% to 17,500 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    12/11/25 6:49:59 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Director Van Heel Kenneth bought $30,812 worth of shares (35,000 units at $0.88), increasing direct ownership by 243% to 49,400 units (SEC Form 4)

    4 - SeaStar Medical Holding Corp (0001831868) (Issuer)

    8/28/25 5:28:58 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    $ALAR
    $ICU
    $KZIA
    $LGVN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by SeaStar Medical Holding Corporation

    SC 13G - SeaStar Medical Holding Corp (0001831868) (Subject)

    11/14/24 5:35:52 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Longeveron Inc.

    SC 13G/A - Longeveron Inc. (0001721484) (Subject)

    11/14/24 4:20:18 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Kazia Therapeutics Limited

    SC 13G/A - KAZIA THERAPEUTICS LTD (0001075880) (Subject)

    11/14/24 4:19:36 PM ET
    $KZIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALAR
    $ICU
    $KZIA
    $LGVN
    Leadership Updates

    Live Leadership Updates

    View All

    Longeveron® Appoints Stephen H. Willard as Chief Executive Officer

    Mr. Willard has a 30+ year track record of leadership across public and private sectors as CEO of multiple biotechnology and pharmaceutical firms, with an impressive history of delivering significant fundraises and strategic collaborationsCorporate focus on delivering top-line results from the pivotal Phase 2b clinical trial in Hypoplastic Left Heart Syndrome (HLHS), anticipated in the third quarter of 2026 Than Powell stepped down as interim CEO; will remain with the Company to support the leadership transition and continue his work in the Company's on-going business development activities MIAMI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerati

    2/13/26 4:30:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    SeaStar Medical Announces Appointment of Michael Messinger as CFO

    DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that Michael Messinger, a seasoned healthcare executive with over 25 years of industry experience, has joined SeaStar Medical as Chief Financial Officer. "Mike brings to SeaStar Medical a breadth of financial expertise, operational discipline, and strategic healthcare experience that will be invaluable as we grow our commercial operations and prepare for additional commercial opportunities for our SCD therapy," stated Eric Schlorff, CE

    11/17/25 8:43:00 AM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    $ALAR
    $ICU
    $KZIA
    $LGVN
    Financials

    Live finance-specific insights

    View All

    Alarum Technologies Reports Fourth Quarter and Full Year 2025 Results

    Revenues for fourth quarter and full year 2025 of $11.8 million and $40.7 million, up 60% and 28% respectively, year-over-year; the strong growth driven by accelerating AI demand Investing strongly in enhancing capabilities, while remaining profitable with FY 2025 net profit of $1.0 million and adjusted EBITDA of $4.4 million TEL AVIV, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq: ALAR, TASE: ALAR) ("Alarum" or the "Company"), a global provider of web data collection solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Financial Highlights of Full Year 2025 2025 revenues of $40.7 million, up 28% ye

    3/19/26 8:00:00 AM ET
    $ALAR
    Computer Software: Prepackaged Software
    Technology

    SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

    DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its fourth quarter and year-end 2025 financial results after market close on Wednesday, March 25, 2026, and host a webcast and conference call to discuss its financial results and business progress. Date/Time:Wednesday, March 25, 2026, at 4:30 p.m. ET / 2:30 p.m. MT  Webcast:The live webcast and replay can be found here.  Register for the call:Preregistration is required to attend the live call and can be accessed h

    3/18/26 4:05:00 PM ET
    $ICU
    Medical/Dental Instruments
    Health Care

    Longeveron Announces 2025 Full Year Financial Results and Provides Business Update

    On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan-designated indicationELPIS II may serve as foundation for a Biologics License Application (BLA) submission for full approval for HLHS, if results demonstrate sufficient evidence of efficacyClosed a private placement of up to $30 million, with $15 million funded in the initial closing, led by Coastlands Capital with participation from Janus Henderson Investors and other healthcare focused fundsCompany to host conference call and webcast today at 4:30 p.m. ET MIAMI, March 17

    3/17/26 4:05:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care